|
The Annexin A2 System and Vascular Homeostasis.
Vascul Pharmacol. 2011 Mar; Epub ahead of print Mar
Flood EC, Hajjar KA. |
|
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.
Lancet. 2011 Mar; 377(9771):1096-101-1101.e1-2..
http://www.ncbi.nlm.nih.gov/pubmed/21439633 |
|
Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels are not Associated With Glucose Intolerance and Subclinical Atherosclerosis in Women With Previous Gestational Diabetes.
Clin Appl Thromb Hemost. 2011 Mar; Epub ahead of print Mar
Akinci B, Celtik A, Yener S, Genc S, Tunali S, Yuksel F, Ozcan MA, Secil M, Yesil S. |
|
Effect of time to electrocardiogram on time from electrocardiogram to fibrinolysis in acute myocardial infarction patients.
CJEM. 2011 Mar; 13(2):79-89.
Atzema CL, Austin PC, Tu JV, Schull MJ. |
|
Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysis
J Thromb Thrombolysis. 2011 Feb; Epub ahead of print Feb
Ahmed S, Michael Gibson C, Cannon CP, Murphy SA, Sabatine MS. |
|
Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy
J Thromb Thrombolysis. 2011 Feb; Epub ahead of print Feb
Agirbasli M, Eren M, Eren F, Murphy SB, Serdar ZA, Seckin D, Zara T, Cem Mat M, Demirkesen C, Vaughan DE. |
|
Relationship between risk stratification at admission and treatment effects of early invasive management following fibrinolysis: insights from the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial
Eur Heart J. . 2011 Feb; Epub ahead of print Feb
Yan AT, Yan RT, Cantor WJ, Borgundvaag B, Cohen EA, Fitchett DH, Dzavik V, Ducas J, Tan M, Casanova A, Goodman SG; for the TRANSFER-AMI Investigators. |
|
The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST
Am Heart J. . 2011 Feb; 161(2):283-90.
Westerhout CM, Bonnefoy E, Welsh RC, Steg PG, Boutitie F, Armstrong PW. |
|
Primary percutaneous coronary intervention for acute myocardial infarction: Is it worth the wait? The risk-time relationship and the need to quantify the impact of delay
Am Heart J. 2011 Feb; 161(2):247-53. Epub 2010 Dic 24
Tarantini G, Van de Werf F, Bilato C, Gersh B. |
|
Antifibrinolytics in women with menorrhagia
Thromb Res. 2011 Feb; 127(Suppl 3:S113-5.)
Philipp CS. |
|
Effectiveness and Safety of Percutaneous Coronary Intervention After Fibrinolytic Therapy for ST-Segment Elevation Acute Myocardial Infarction
Am J Cardiol. 2011 Ene; Epub ahead of print Dic
Baron SJ, Giugliano RP.Am J Cardiol. |
|
Abnormal plasma fibrin clot characteristics are associated with worse clinical outcome in patients with peripheral arterial disease and thromboangiitis obliterans
Atherosclerosis. 2011 Ene; Epub ahead of print Dic
Undas A, Nowakowski T, Cie?la-Dul M, Sadowski J. |
|
Reduction of adhesion formation by an angiotensin type 1 receptor antagonist.
Langenbecks Arch Surg. 2010 Jul; Epub ahead of print Feb
Tokinaga Y, Kimoto Y, Ogawa K, Mizumoto K, Tange K, Hatano Y. |
|
Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies.
J Reprod Immunol. 2010 Jun; Epub ahead of print Feb
Martínez-Zamora MA, Tassies D, Carmona F, Espinosa G, Cervera R, Reverter JC, Balasch J. |
|
Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis.
J Thromb Haemost. 2010 Jun; Epub ahead of print Feb
Mutch NJ, Koikkalainen JS, Fraser SR, Duthie KM, Griffin M, Mitchell J, Watson HG, Booth NA. |
|
Blood coagulation and fibrinolysis after experimental subarachnoid hemorrhage.
Acta Neurochir (Wien). 2010 Jun; Epub ahead of print Feb
Larsen CC, Hansen-Schwartz J, Nielsen JD, Astrup J. |
|
Factor XII bridges coagulation and fibrinolysis again.
Blood. 2010 Jun; 115(24):4979-80. No abstract available Feb
Gonias SL. |
|
Delays in fibrinolysis as primary reperfusion therapy for acute ST-segment elevation myocardial infarction.
Am Heart J. 2010 Jun; 159(6):998-1004.e2.
Glickman SW, Cairns CB, Chen AY, Peterson ED, Roe MT. |
|
Increased tissue kallikrein levels in type 2 diabetes.
Diabetologia.. 2010 Abr; 53(4):779-758.
Campbell DJ, Kladis A, Zhang Y, Jenkins AJ, Prior DL, Yii M, Kenny JF, Black MJ, Kelly DJ. |
|
Fibrinolysis Versus Primary Percutaneous Intervention in ST-elevation Myocardial Infarction With Long Interhospital Transfer Distances.
Clin Cardiol. 2010 Mar; 33(3):162-167.
Beri A, Printz M, Hassan A, Babb JD. |
